迈得医疗
(688310)
| 流通市值：27.94亿 | | | 总市值：27.94亿 |
| 流通股本：1.18亿 | | | 总股本：1.18亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 74,220,852.42 | 480,220,256 | 329,920,089.5 | 197,664,011.37 |
| 营业收入 | 74,220,852.42 | 480,220,256 | 329,920,089.5 | 197,664,011.37 |
| 二、营业总成本 | 71,608,393.2 | 384,333,032.62 | 258,621,577.77 | 161,541,867.16 |
| 营业成本 | 34,507,374.64 | 229,198,523.48 | 147,433,737.94 | 93,608,316.99 |
| 税金及附加 | 1,466,181.49 | 6,880,612.24 | 4,752,538.81 | 2,757,870.29 |
| 销售费用 | 5,296,950.73 | 32,212,873.29 | 16,772,936.64 | 10,136,311.95 |
| 管理费用 | 21,440,815.64 | 90,429,822.31 | 68,514,722.21 | 44,955,720.58 |
| 研发费用 | 9,880,803.8 | 33,176,643.68 | 26,700,469.34 | 14,317,161.77 |
| 财务费用 | -983,733.1 | -7,565,442.38 | -5,552,827.17 | -4,233,514.42 |
| 其中:利息费用 | 24,179.1 | 76,290.31 | 53,241.97 | 31,713.87 |
| 其中:利息收入 | 1,099,878.8 | 7,193,230.28 | 5,348,955.74 | 3,685,595.51 |
| 加:公允价值变动收益 | 591,418.33 | 2,659,119.87 | 2,051,753.35 | 1,511,097.8 |
| 加:投资收益 | 8,557.05 | 65,440.87 | -144,810.69 | -206,842.98 |
| 资产处置收益 | 130,401.41 | 101,695.82 | 41,035.59 | 41,035.59 |
| 资产减值损失(新) | -377,939 | -2,255,424.47 | -448,020 | 52,950 |
| 信用减值损失(新) | 1,575,038.97 | -3,221,085.35 | -491,012.61 | 799,032.68 |
| 其他收益 | 6,048,219.18 | 34,734,488.93 | 24,384,649.35 | 14,280,366.28 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 10,588,155.16 | 127,971,459.05 | 96,692,106.72 | 52,599,783.58 |
| 加:营业外收入 | 1,400 | 421,633.04 | 410,000 | - |
| 减:营业外支出 | 101,405.31 | 962,159.13 | 388,108.17 | 163,108.17 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 10,488,149.85 | 127,430,932.96 | 96,713,998.55 | 52,436,675.41 |
| 减:所得税费用 | 873,990.62 | 17,823,654.82 | 14,832,055.78 | 7,594,185.74 |
| 六、净利润 | 9,614,159.23 | 109,607,278.14 | 81,881,942.77 | 44,842,489.67 |
| 持续经营净利润 | 9,614,159.23 | 109,607,278.14 | 81,881,942.77 | 44,842,489.67 |
| 归属于母公司股东的净利润 | 10,513,161.2 | 99,828,173.71 | 71,765,299.89 | 39,873,383.43 |
| 少数股东损益 | -899,001.97 | 9,779,104.43 | 10,116,642.88 | 4,969,106.24 |
| (一)基本每股收益 | 0.09 | 0.85 | 0.61 | 0.34 |
| (二)稀释每股收益 | 0.09 | 0.84 | 0.6 | 0.34 |
| 八、其他综合收益 | 174,622.57 | -415,959.28 | -150,586.72 | -402,744.43 |
| 归属于母公司股东的其他综合收益 | 174,622.57 | -415,959.28 | -150,586.72 | -402,744.43 |
| 九、综合收益总额 | 9,788,781.8 | 109,191,318.86 | 81,731,356.05 | 44,439,745.24 |
| 归属于母公司股东的综合收益总额 | 10,687,783.77 | 99,412,214.43 | 71,614,713.17 | 39,470,639 |
| 归属于少数股东的综合收益总额 | -899,001.97 | 9,779,104.43 | 10,116,642.88 | 4,969,106.24 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-27 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |